
Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
Members can obtain an early refill if it is on file at a participating pharmacy.
Responding to the floods that have now affected seven Midwestern states,
To see more Daily News articles,
To go to the Drug Topics homepage,





